comparemela.com

Page 5 - Mel Sorensen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Galera Therapeutics : Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives with decades of experience successfully launching and commercializing new oncology products - Form 8-K

Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives. | May 11, 2023

Community Calendar - Chesterton Tribune

Community Calendar - Chesterton Tribune
chestertontribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chestertontribune.com Daily Mail and Mail on Sunday newspapers.

Galera Therapeutics (NASDAQ:GRTX) Trading Down 1 2%

Galera Therapeutics, Inc. (NASDAQ:GRTX – Get Rating)’s stock price was down 1.2% during trading on Tuesday . The stock traded as low as $3.23 and last traded at $3.27. Approximately 538,727 shares were traded during mid-day trading, a decline of 13% from the average daily volume of 616,913 shares. The stock had previously closed at […]

Galera Therapeutics (NASDAQ:GRTX) Trading Down 1 2%

Galera Therapeutics, Inc. (NASDAQ:GRTX – Get Rating)’s stock price was down 1.2% during trading on Tuesday . The stock traded as low as $3.23 and last traded at $3.27. Approximately 538,727 shares were traded during mid-day trading, a decline of 13% from the average daily volume of 616,913 shares. The stock had previously closed at […]

Galera Therapeutics (NASDAQ:GRTX) PT Lowered to $6 00 at HC Wainwright

Galera Therapeutics (NASDAQ:GRTX – Get Rating) had its price objective lowered by HC Wainwright from $10.00 to $6.00 in a research report released on Wednesday morning, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Galera Therapeutics’ Q1 2023 earnings at ($0.31) EPS, Q2 2023 […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.